Global Plasmid DNA CDMO Market Research Report 2023
According to QYResearch’s new survey, global Plasmid DNA CDMO market is projected to reach US$ 664 million in 2029, increasing from US$ 168.9 million in 2022, with the CAGR of 22.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasmid DNA CDMO market research.
Key companies engaged in the Plasmid DNA CDMO industry include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Plasmid DNA CDMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Plasmid DNA CDMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasmid DNA CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Key companies engaged in the Plasmid DNA CDMO industry include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Plasmid DNA CDMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Plasmid DNA CDMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Plasmid DNA CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- GenScript ProBio
- Biovian
- Biomay
- VGXI
- Esco Aster
- Catalent
- Richter-Helm BioLogics
- Cytovance Biologics
- Cobra Biologics
- Obiosh
- Thermo Fisher
- Aldevron(Danaher)
- Charles River Laboratories
- WuXi AppTec
- AGC Biologics
- AcuraBio
- GENE Chem
- Eurogentec
- PlasmidFactory
- GMP Grade Plasmid DNA
- Non-GMP Grade Plasmid DNA
- DNA Vaccines
- Gene Therapy
- Immunotherapy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Plasmid DNA CDMO Market Perspective (2018-2029)
2.2 Plasmid DNA CDMO Growth Trends by Region
2.2.1 Global Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2018-2023)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Plasmid DNA CDMO Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Players by Revenue (2018-2023)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA CDMO Revenue
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2022
3.5 Plasmid DNA CDMO Key Players Head office and Area Served
3.6 Key Players Plasmid DNA CDMO Product Solution and Service
3.7 Date of Enter into Plasmid DNA CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PLASMID DNA CDMO BREAKDOWN DATA BY TYPE
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2018-2023)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029)
5 PLASMID DNA CDMO BREAKDOWN DATA BY APPLICATION
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2018-2023)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasmid DNA CDMO Market Size (2018-2029)
6.2 North America Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid DNA CDMO Market Size by Country (2018-2023)
6.4 North America Plasmid DNA CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Plasmid DNA CDMO Market Size (2018-2029)
7.2 Europe Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid DNA CDMO Market Size by Country (2018-2023)
7.4 Europe Plasmid DNA CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasmid DNA CDMO Market Size (2018-2029)
8.2 Asia-Pacific Plasmid DNA CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Plasmid DNA CDMO Market Size (2018-2029)
9.2 Latin America Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid DNA CDMO Market Size by Country (2018-2023)
9.4 Latin America Plasmid DNA CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasmid DNA CDMO Market Size (2018-2029)
10.2 Middle East & Africa Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Detail
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2023)
11.1.5 GenScript ProBio Recent Development
11.2 Biovian
11.2.1 Biovian Company Detail
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2018-2023)
11.2.5 Biovian Recent Development
11.3 Biomay
11.3.1 Biomay Company Detail
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2018-2023)
11.3.5 Biomay Recent Development
11.4 VGXI
11.4.1 VGXI Company Detail
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2018-2023)
11.4.5 VGXI Recent Development
11.5 Esco Aster
11.5.1 Esco Aster Company Detail
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2023)
11.5.5 Esco Aster Recent Development
11.6 Catalent
11.6.1 Catalent Company Detail
11.6.2 Catalent Business Overview
11.6.3 Catalent Plasmid DNA CDMO Introduction
11.6.4 Catalent Revenue in Plasmid DNA CDMO Business (2018-2023)
11.6.5 Catalent Recent Development
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Detail
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.7.5 Richter-Helm BioLogics Recent Development
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Detail
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.8.5 Cytovance Biologics Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Detail
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.9.5 Cobra Biologics Recent Development
11.10 Obiosh
11.10.1 Obiosh Company Detail
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2018-2023)
11.10.5 Obiosh Recent Development
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Detail
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2023)
11.11.5 Thermo Fisher Recent Development
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Detail
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2023)
11.12.5 Aldevron(Danaher) Recent Development
11.13 Charles River Laboratories
11.13.1 Charles River Laboratories Company Detail
11.13.2 Charles River Laboratories Business Overview
11.13.3 Charles River Laboratories Plasmid DNA CDMO Introduction
11.13.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2023)
11.13.5 Charles River Laboratories Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Detail
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.14.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2023)
11.14.5 WuXi AppTec Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Detail
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics Plasmid DNA CDMO Introduction
11.15.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.15.5 AGC Biologics Recent Development
11.16 AcuraBio
11.16.1 AcuraBio Company Detail
11.16.2 AcuraBio Business Overview
11.16.3 AcuraBio Plasmid DNA CDMO Introduction
11.16.4 AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2023)
11.16.5 AcuraBio Recent Development
11.17 GENE Chem
11.17.1 GENE Chem Company Detail
11.17.2 GENE Chem Business Overview
11.17.3 GENE Chem Plasmid DNA CDMO Introduction
11.17.4 GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2023)
11.17.5 GENE Chem Recent Development
11.18 Eurogentec
11.18.1 Eurogentec Company Detail
11.18.2 Eurogentec Business Overview
11.18.3 Eurogentec Plasmid DNA CDMO Introduction
11.18.4 Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2023)
11.18.5 Eurogentec Recent Development
11.19 PlasmidFactory
11.19.1 PlasmidFactory Company Detail
11.19.2 PlasmidFactory Business Overview
11.19.3 PlasmidFactory Plasmid DNA CDMO Introduction
11.19.4 PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2023)
11.19.5 PlasmidFactory Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Plasmid DNA CDMO Market Perspective (2018-2029)
2.2 Plasmid DNA CDMO Growth Trends by Region
2.2.1 Global Plasmid DNA CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2018-2023)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Plasmid DNA CDMO Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Players by Revenue (2018-2023)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA CDMO Revenue
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2022
3.5 Plasmid DNA CDMO Key Players Head office and Area Served
3.6 Key Players Plasmid DNA CDMO Product Solution and Service
3.7 Date of Enter into Plasmid DNA CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PLASMID DNA CDMO BREAKDOWN DATA BY TYPE
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2018-2023)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029)
5 PLASMID DNA CDMO BREAKDOWN DATA BY APPLICATION
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2018-2023)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Plasmid DNA CDMO Market Size (2018-2029)
6.2 North America Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid DNA CDMO Market Size by Country (2018-2023)
6.4 North America Plasmid DNA CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Plasmid DNA CDMO Market Size (2018-2029)
7.2 Europe Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid DNA CDMO Market Size by Country (2018-2023)
7.4 Europe Plasmid DNA CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Plasmid DNA CDMO Market Size (2018-2029)
8.2 Asia-Pacific Plasmid DNA CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Plasmid DNA CDMO Market Size (2018-2029)
9.2 Latin America Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid DNA CDMO Market Size by Country (2018-2023)
9.4 Latin America Plasmid DNA CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Plasmid DNA CDMO Market Size (2018-2029)
10.2 Middle East & Africa Plasmid DNA CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Detail
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2023)
11.1.5 GenScript ProBio Recent Development
11.2 Biovian
11.2.1 Biovian Company Detail
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2018-2023)
11.2.5 Biovian Recent Development
11.3 Biomay
11.3.1 Biomay Company Detail
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2018-2023)
11.3.5 Biomay Recent Development
11.4 VGXI
11.4.1 VGXI Company Detail
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2018-2023)
11.4.5 VGXI Recent Development
11.5 Esco Aster
11.5.1 Esco Aster Company Detail
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2023)
11.5.5 Esco Aster Recent Development
11.6 Catalent
11.6.1 Catalent Company Detail
11.6.2 Catalent Business Overview
11.6.3 Catalent Plasmid DNA CDMO Introduction
11.6.4 Catalent Revenue in Plasmid DNA CDMO Business (2018-2023)
11.6.5 Catalent Recent Development
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Detail
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.7.5 Richter-Helm BioLogics Recent Development
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Detail
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.8.5 Cytovance Biologics Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Detail
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.9.5 Cobra Biologics Recent Development
11.10 Obiosh
11.10.1 Obiosh Company Detail
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2018-2023)
11.10.5 Obiosh Recent Development
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Detail
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2023)
11.11.5 Thermo Fisher Recent Development
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Detail
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2023)
11.12.5 Aldevron(Danaher) Recent Development
11.13 Charles River Laboratories
11.13.1 Charles River Laboratories Company Detail
11.13.2 Charles River Laboratories Business Overview
11.13.3 Charles River Laboratories Plasmid DNA CDMO Introduction
11.13.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2023)
11.13.5 Charles River Laboratories Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Detail
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.14.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2023)
11.14.5 WuXi AppTec Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Detail
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics Plasmid DNA CDMO Introduction
11.15.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2023)
11.15.5 AGC Biologics Recent Development
11.16 AcuraBio
11.16.1 AcuraBio Company Detail
11.16.2 AcuraBio Business Overview
11.16.3 AcuraBio Plasmid DNA CDMO Introduction
11.16.4 AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2023)
11.16.5 AcuraBio Recent Development
11.17 GENE Chem
11.17.1 GENE Chem Company Detail
11.17.2 GENE Chem Business Overview
11.17.3 GENE Chem Plasmid DNA CDMO Introduction
11.17.4 GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2023)
11.17.5 GENE Chem Recent Development
11.18 Eurogentec
11.18.1 Eurogentec Company Detail
11.18.2 Eurogentec Business Overview
11.18.3 Eurogentec Plasmid DNA CDMO Introduction
11.18.4 Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2023)
11.18.5 Eurogentec Recent Development
11.19 PlasmidFactory
11.19.1 PlasmidFactory Company Detail
11.19.2 PlasmidFactory Business Overview
11.19.3 PlasmidFactory Plasmid DNA CDMO Introduction
11.19.4 PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2023)
11.19.5 PlasmidFactory Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of GMP Grade Plasmid DNA
Table 3. Key Players of Non-GMP Grade Plasmid DNA
Table 4. Global Plasmid DNA CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Plasmid DNA CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Plasmid DNA CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Plasmid DNA CDMO Market Share by Region (2018-2023)
Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Plasmid DNA CDMO Market Share by Region (2024-2029)
Table 10. Plasmid DNA CDMO Market Trends
Table 11. Plasmid DNA CDMO Market Drivers
Table 12. Plasmid DNA CDMO Market Challenges
Table 13. Plasmid DNA CDMO Market Restraints
Table 14. Global Plasmid DNA CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Plasmid DNA CDMO Market Share by Players (2018-2023)
Table 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Table 17. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasmid DNA CDMO Product Solution and Service
Table 21. Date of Enter into Plasmid DNA CDMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasmid DNA CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2018-2023)
Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2024-2029)
Table 27. Global Plasmid DNA CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Plasmid DNA CDMO Revenue Market Share by Application (2018-2023)
Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Plasmid DNA CDMO Revenue Market Share by Application (2024-2029)
Table 31. North America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Plasmid DNA CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 46. GenScript ProBio Company Detail
Table 47. GenScript ProBio Business Overview
Table 48. GenScript ProBio Plasmid DNA CDMO Product
Table 49. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 50. GenScript ProBio Recent Development
Table 51. Biovian Company Detail
Table 52. Biovian Business Overview
Table 53. Biovian Plasmid DNA CDMO Product
Table 54. Biovian Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 55. Biovian Recent Development
Table 56. Biomay Company Detail
Table 57. Biomay Business Overview
Table 58. Biomay Plasmid DNA CDMO Product
Table 59. Biomay Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 60. Biomay Recent Development
Table 61. VGXI Company Detail
Table 62. VGXI Business Overview
Table 63. VGXI Plasmid DNA CDMO Product
Table 64. VGXI Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 65. VGXI Recent Development
Table 66. Esco Aster Company Detail
Table 67. Esco Aster Business Overview
Table 68. Esco Aster Plasmid DNA CDMO Product
Table 69. Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 70. Esco Aster Recent Development
Table 71. Catalent Company Detail
Table 72. Catalent Business Overview
Table 73. Catalent Plasmid DNA CDMO Product
Table 74. Catalent Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 75. Catalent Recent Development
Table 76. Richter-Helm BioLogics Company Detail
Table 77. Richter-Helm BioLogics Business Overview
Table 78. Richter-Helm BioLogics Plasmid DNA CDMO Product
Table 79. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 80. Richter-Helm BioLogics Recent Development
Table 81. Cytovance Biologics Company Detail
Table 82. Cytovance Biologics Business Overview
Table 83. Cytovance Biologics Plasmid DNA CDMO Product
Table 84. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 85. Cytovance Biologics Recent Development
Table 86. Cobra Biologics Company Detail
Table 87. Cobra Biologics Business Overview
Table 88. Cobra Biologics Plasmid DNA CDMO Product
Table 89. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 90. Cobra Biologics Recent Development
Table 91. Obiosh Company Detail
Table 92. Obiosh Business Overview
Table 93. Obiosh Plasmid DNA CDMO Product
Table 94. Obiosh Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 95. Obiosh Recent Development
Table 96. Thermo Fisher Company Detail
Table 97. Thermo Fisher Business Overview
Table 98. Thermo Fisher Plasmid DNA CDMO Product
Table 99. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 100. Thermo Fisher Recent Development
Table 101. Aldevron(Danaher) Company Detail
Table 102. Aldevron(Danaher) Business Overview
Table 103. Aldevron(Danaher) Plasmid DNA CDMO Product
Table 104. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 105. Aldevron(Danaher) Recent Development
Table 106. Charles River Laboratories Company Detail
Table 107. Charles River Laboratories Business Overview
Table 108. Charles River Laboratories Plasmid DNA CDMO Product
Table 109. Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 110. Charles River Laboratories Recent Development
Table 111. WuXi AppTec Company Detail
Table 112. WuXi AppTec Business Overview
Table 113. WuXi AppTec Plasmid DNA CDMO Product
Table 114. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 115. WuXi AppTec Recent Development
Table 116. AGC Biologics Company Detail
Table 117. AGC Biologics Business Overview
Table 118. AGC Biologics Plasmid DNA CDMO Product
Table 119. AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 120. AGC Biologics Recent Development
Table 121. AcuraBio Company Detail
Table 122. AcuraBio Business Overview
Table 123. AcuraBio Plasmid DNA CDMO Product
Table 124. AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 125. AcuraBio Recent Development
Table 126. GENE Chem Company Detail
Table 127. GENE Chem Business Overview
Table 128. GENE Chem Plasmid DNA CDMO Product
Table 129. GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 130. GENE Chem Recent Development
Table 131. Eurogentec Company Detail
Table 132. Eurogentec Business Overview
Table 133. Eurogentec Plasmid DNA CDMO Product
Table 134. Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 135. Eurogentec Recent Development
Table 136. PlasmidFactory Company Detail
Table 137. PlasmidFactory Business Overview
Table 138. PlasmidFactory Plasmid DNA CDMO Product
Table 139. PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 140. PlasmidFactory Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of GMP Grade Plasmid DNA
Table 3. Key Players of Non-GMP Grade Plasmid DNA
Table 4. Global Plasmid DNA CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Plasmid DNA CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Plasmid DNA CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Plasmid DNA CDMO Market Share by Region (2018-2023)
Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Plasmid DNA CDMO Market Share by Region (2024-2029)
Table 10. Plasmid DNA CDMO Market Trends
Table 11. Plasmid DNA CDMO Market Drivers
Table 12. Plasmid DNA CDMO Market Challenges
Table 13. Plasmid DNA CDMO Market Restraints
Table 14. Global Plasmid DNA CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Plasmid DNA CDMO Market Share by Players (2018-2023)
Table 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Table 17. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasmid DNA CDMO Product Solution and Service
Table 21. Date of Enter into Plasmid DNA CDMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasmid DNA CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2018-2023)
Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2024-2029)
Table 27. Global Plasmid DNA CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Plasmid DNA CDMO Revenue Market Share by Application (2018-2023)
Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Plasmid DNA CDMO Revenue Market Share by Application (2024-2029)
Table 31. North America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Plasmid DNA CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 46. GenScript ProBio Company Detail
Table 47. GenScript ProBio Business Overview
Table 48. GenScript ProBio Plasmid DNA CDMO Product
Table 49. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 50. GenScript ProBio Recent Development
Table 51. Biovian Company Detail
Table 52. Biovian Business Overview
Table 53. Biovian Plasmid DNA CDMO Product
Table 54. Biovian Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 55. Biovian Recent Development
Table 56. Biomay Company Detail
Table 57. Biomay Business Overview
Table 58. Biomay Plasmid DNA CDMO Product
Table 59. Biomay Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 60. Biomay Recent Development
Table 61. VGXI Company Detail
Table 62. VGXI Business Overview
Table 63. VGXI Plasmid DNA CDMO Product
Table 64. VGXI Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 65. VGXI Recent Development
Table 66. Esco Aster Company Detail
Table 67. Esco Aster Business Overview
Table 68. Esco Aster Plasmid DNA CDMO Product
Table 69. Esco Aster Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 70. Esco Aster Recent Development
Table 71. Catalent Company Detail
Table 72. Catalent Business Overview
Table 73. Catalent Plasmid DNA CDMO Product
Table 74. Catalent Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 75. Catalent Recent Development
Table 76. Richter-Helm BioLogics Company Detail
Table 77. Richter-Helm BioLogics Business Overview
Table 78. Richter-Helm BioLogics Plasmid DNA CDMO Product
Table 79. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 80. Richter-Helm BioLogics Recent Development
Table 81. Cytovance Biologics Company Detail
Table 82. Cytovance Biologics Business Overview
Table 83. Cytovance Biologics Plasmid DNA CDMO Product
Table 84. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 85. Cytovance Biologics Recent Development
Table 86. Cobra Biologics Company Detail
Table 87. Cobra Biologics Business Overview
Table 88. Cobra Biologics Plasmid DNA CDMO Product
Table 89. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 90. Cobra Biologics Recent Development
Table 91. Obiosh Company Detail
Table 92. Obiosh Business Overview
Table 93. Obiosh Plasmid DNA CDMO Product
Table 94. Obiosh Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 95. Obiosh Recent Development
Table 96. Thermo Fisher Company Detail
Table 97. Thermo Fisher Business Overview
Table 98. Thermo Fisher Plasmid DNA CDMO Product
Table 99. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 100. Thermo Fisher Recent Development
Table 101. Aldevron(Danaher) Company Detail
Table 102. Aldevron(Danaher) Business Overview
Table 103. Aldevron(Danaher) Plasmid DNA CDMO Product
Table 104. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 105. Aldevron(Danaher) Recent Development
Table 106. Charles River Laboratories Company Detail
Table 107. Charles River Laboratories Business Overview
Table 108. Charles River Laboratories Plasmid DNA CDMO Product
Table 109. Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 110. Charles River Laboratories Recent Development
Table 111. WuXi AppTec Company Detail
Table 112. WuXi AppTec Business Overview
Table 113. WuXi AppTec Plasmid DNA CDMO Product
Table 114. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 115. WuXi AppTec Recent Development
Table 116. AGC Biologics Company Detail
Table 117. AGC Biologics Business Overview
Table 118. AGC Biologics Plasmid DNA CDMO Product
Table 119. AGC Biologics Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 120. AGC Biologics Recent Development
Table 121. AcuraBio Company Detail
Table 122. AcuraBio Business Overview
Table 123. AcuraBio Plasmid DNA CDMO Product
Table 124. AcuraBio Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 125. AcuraBio Recent Development
Table 126. GENE Chem Company Detail
Table 127. GENE Chem Business Overview
Table 128. GENE Chem Plasmid DNA CDMO Product
Table 129. GENE Chem Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 130. GENE Chem Recent Development
Table 131. Eurogentec Company Detail
Table 132. Eurogentec Business Overview
Table 133. Eurogentec Plasmid DNA CDMO Product
Table 134. Eurogentec Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 135. Eurogentec Recent Development
Table 136. PlasmidFactory Company Detail
Table 137. PlasmidFactory Business Overview
Table 138. PlasmidFactory Plasmid DNA CDMO Product
Table 139. PlasmidFactory Revenue in Plasmid DNA CDMO Business (2018-2023) & (US$ Million)
Table 140. PlasmidFactory Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Plasmid DNA CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Plasmid DNA CDMO Market Share by Type: 2022 VS 2029
Figure 3. GMP Grade Plasmid DNA Features
Figure 4. Non-GMP Grade Plasmid DNA Features
Figure 5. Global Plasmid DNA CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Plasmid DNA CDMO Market Share by Application: 2022 VS 2029
Figure 7. DNA Vaccines Case Studies
Figure 8. Gene Therapy Case Studies
Figure 9. Immunotherapy Case Studies
Figure 10. Others Case Studies
Figure 11. Plasmid DNA CDMO Report Years Considered
Figure 12. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Plasmid DNA CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Plasmid DNA CDMO Market Share by Region: 2022 VS 2029
Figure 15. Global Plasmid DNA CDMO Market Share by Players in 2022
Figure 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2022
Figure 18. North America Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 20. United States Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 24. Germany Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Plasmid DNA CDMO Market Share by Region (2018-2029)
Figure 32. China Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 40. Mexico Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 44. Turkey Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 47. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 48. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 49. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 50. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 51. Catalent Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 52. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 53. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 54. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 55. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 56. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 57. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 58. Charles River Laboratories Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 59. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 60. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 61. AcuraBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 62. GENE Chem Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 63. Eurogentec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 64. PlasmidFactory Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Plasmid DNA CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Plasmid DNA CDMO Market Share by Type: 2022 VS 2029
Figure 3. GMP Grade Plasmid DNA Features
Figure 4. Non-GMP Grade Plasmid DNA Features
Figure 5. Global Plasmid DNA CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Plasmid DNA CDMO Market Share by Application: 2022 VS 2029
Figure 7. DNA Vaccines Case Studies
Figure 8. Gene Therapy Case Studies
Figure 9. Immunotherapy Case Studies
Figure 10. Others Case Studies
Figure 11. Plasmid DNA CDMO Report Years Considered
Figure 12. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Plasmid DNA CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Plasmid DNA CDMO Market Share by Region: 2022 VS 2029
Figure 15. Global Plasmid DNA CDMO Market Share by Players in 2022
Figure 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2022
Figure 18. North America Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 20. United States Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 24. Germany Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Plasmid DNA CDMO Market Share by Region (2018-2029)
Figure 32. China Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 40. Mexico Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Plasmid DNA CDMO Market Share by Country (2018-2029)
Figure 44. Turkey Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 47. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 48. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 49. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 50. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 51. Catalent Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 52. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 53. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 54. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 55. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 56. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 57. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 58. Charles River Laboratories Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 59. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 60. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 61. AcuraBio Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 62. GENE Chem Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 63. Eurogentec Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 64. PlasmidFactory Revenue Growth Rate in Plasmid DNA CDMO Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
